Tirzep 7.5 mg (Tirzepatide) Tablets
Introduction Tirzep 7.5 mg (Tirzepatide) is an intermediate-strength therapeutic formulation of a first-in-class dual metabolic pathway therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and distributed globally by Onco Solution, Tirzep 7.5 mg serves as a critical bridge and maintenance tier in metabolic treatment. […]
Tirzep 5 mg (Tirzepatide) Tablets
Introduction Tirzep 5 mg (Tirzepatide) is the primary therapeutic maintenance formulation of a first-in-class dual metabolic pathway therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and distributed globally by Onco Solution, Tirzep 5 mg represents the first step-up dosage tier following the initial conditioning […]
Tirzep 2.5 mg (Tirzepatide) Tablets
Introduction Tirzep 2.5 mg (Tirzepatide) is the introductory initiation formulation of a first-in-class dual metabolic pathway therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and distributed globally by Onco Solution, Tirzep 2.5 mg serves as the essential baseline dose for the treatment of metabolic […]
Tirzep 15 mg (Tirzepatide) Tablets
Introduction Tirzep 15 mg (Tirzepatide) is the maximum-strength formulation of a first-in-class dual metabolic pathway therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and distributed globally by Onco Solution, Tirzep 15 mg represents the pinnacle of advanced metabolic and endocrine regulation. This maximal dose […]
Tirzep 12.5 mg (Tirzepatide) Tablets
Introduction Tirzep 12.5 mg (Tirzepatide) is a high-dose, first-in-class dual-acting metabolic therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and supplied globally by Onco Solution, Tirzepatide represents a major evolution in metabolic medicine. The 12.5 mg strength serves as an advanced, high-tier maintenance dose […]
Tirzep 10 mg (Tirzepatide) Tablets
Introduction Tirzep 10 mg (Tirzepatide) is a first-in-class, dual-acting metabolic therapy classified as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Manufactured by ACI Pharmaceuticals PLC and supplied globally by Onco Solution, Tirzepatide represents a major evolutionary leap in metabolic medicine. Originally designed for advanced glycemic control in type 2 diabetes, its […]